W Amy Schulman

Affiliations

  • at Fractyl Health Inc. (GUTS), 2025-06-13
  • Director at Alnylam Pharmaceuticals Inc. (ALNY), 2025-05-12
  • at Camp4 Therapeutics Corp (CAMP), 2024-10-22
  • Large Shareholder, Director at Sqz Biotechnologies Co (SQZ), 2023-06-15
  • Director at Hudson Executive Investment Corp. Ii (HCII), 2021-04-14
  • Director at Cyclerion Therapeutics Inc. (CYCN), 2020-06-18
  • Director at Hudson Executive Investment Corp. (HEC), 2020-06-08
  • Director at Ironwood Pharmaceuticals Inc (IRWD), 2019-04-03
  • Director at Arsanis Inc. (ASNS), 2018-06-07
  • Director at Blue Buffalo Pet Products Inc. (BUFF), 2018-04-24
  • Director at Bind Therapeutics Inc (BIND), 2015-06-10
  • Former Exec. Vice President at Pfizer Inc (PFE), 2014-01-03
  • Director at Zoetis Inc. (ZTS), 2013-02-08
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
GUTS $1.17 8,550 $9,964.17 8,550 2025-03-13 Filing
SQZ $10.94 1,850 $20,239.00 1,850 2021-12-13 Filing
SQZ $10.88 1,850 $20,128.00 1,850 2021-12-13 Filing
SQZ $16.00 233,654 $3,738,464.00 2,549,306 2020-11-03 Filing
SQZ $16.00 16,346 $261,536.00 178,340 2020-11-03 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ALNY $240.00 8,500 $2,040,000.00 8,436 2024-06-25 Filing
ALNY $149.76 63 $9,434.88 8,436 2024-05-29 Filing
ALNY $148.93 11,516 $1,715,077.88 8,499 2024-05-29 Filing
ALNY $148.21 10,121 $1,500,033.41 20,015 2024-05-29 Filing
PFE $29.35 10,598 $311,051.30 223,497 2013-05-15 Filing